Register Today for the Premier Translational Research in Oncology Meeting
7th International Symposium on Translational Research in Oncology
October 16 - 19, 2008
Hyatt Regency Huntington Beach
Huntington Beach, CA
At this premier scientific meeting, the world's leading researchers gather to present data and discuss recent directions in oncology research, with a focus on translating the most recent laboratory developments into the development of treatments that improve clinical outcomes for cancer patients. The program, developed under the direction of co-chairs Dennis J. Slamon, MD, PhD, and John Crown, MD, MPH, includes relevant didactic presentations and compelling, interactive discussions.
Faculty are carefully selected from among the researchers at the forefront of the translational work in the topic, whether from academia, government, or industry. The program encourages networking and interaction between the attendees and the renowned faculty members.
Program Overview
You are invited to attend the premier translational research in oncology meeting, where experts in the field will address the following topics:
-
Growth Factors and Growth Factor Receptors
-
Steroid Hormonal Receptors and Their Manipulation
-
Apoptosis and Programmed Cell Death
-
Malignant Angiogenesis and Antiangiogenic Therapies
-
Malignant Stem Cells as Targets in Oncology
-
Immunotherapies and Vaccine Strategies
-
Signal Transduction: Targets in the Malignant Signaling Process
-
Identification of Signaling Pathways and Genetic Markers in Cancer
Goal
The goal of this activity is to provide an update on major topics in translational research in oncology to biomedical researchers and clinicians.
Target Audience
This activity is intended for biomedical investigators in the area of cancer research from academia and industry, as well as medical, surgical, and radiation oncologists.
Learning Objectives
-
Explain how the elucidation of cellular and signal transduction pathways in cancer facilitates the development of appropriate drug targets
-
Discuss recent data from studies incorporating targeted therapies as single agents and in combination regimens for the treatment of cancer
-
Describe predictive and prognostic strategies that may help clinicians provide patients with more individualized therapies
-
Cite the evolving role of immunotherapy, vaccines, and stem cells in the treatment of cancer
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
In order to receive credit, participants must attend the session and submit a credit application and evaluation form to symposium staff at the end of the program. Certificates will be mailed within 6-8 weeks following the program.
